Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Monotherapy in Newly Diagnosed or Recurrent Epilepsy
NCT00231556Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 1999
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of topiramate in epilepsy (2 arms), sponsored by Johnson & Johnson. Primary endpoint: Time to first seizure. Started Jul 1999; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00231556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231556.